1.
Lima MR, Farias LABG, da Ponte MF, Furtado LET de A. Self-Limited Cytomegalovirus Infection During Natalizumab Treatment for Multiple Sclerosis. EJCRIM 2019;6 doi:10.12890/2019_001046.